AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Clinical trials for AMYOTROPHIC LATERAL SCLEROSIS (ALS) explained in plain language.

Never miss a new study

Get alerted when new AMYOTROPHIC LATERAL SCLEROSIS (ALS) trials appear

Sign up with your email to follow new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 15 Not yet recruiting 7 Not yet finished but already full! 5 Completed 6 Terminated 1

ALS drug trial extended to check Long-Term safety

Disease control Terminated

This study aimed to check the long-term safety of an oral medication called SPG302 for people with ALS (Lou Gehrig's disease). It was an extension of an earlier trial, allowing 16 participants to continue taking the drug for up to one year. The main goal was to monitor side effec…

Matched conditions: AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Get alerted when new AMYOTROPHIC LATERAL SCLEROSIS (ALS) trials appear

ALS drug trial extended to check Long-Term safety